Nektar Therapeutics
NKTR
NKTR
257 hedge funds and large institutions have $4.05B invested in Nektar Therapeutics in 2020 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 95 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
257
Holders Change
+15
Holders Change %
+6.2%
% of All Funds
5.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
41
Increased
75
Reduced
95
Closed
24
Calls
$23.7M
Puts
$21.8M
Net Calls
+$1.91M
Net Calls Change
+$9.35M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$20.3M |
| 2 |
BlackRock
New York
|
+$14.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$11.8M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$6.68M |
| 5 |
Two Sigma Investments
New York
|
+$6.5M |
Top Sellers
| 1 |
Primecap Management
Pasadena,
California
|
-$24.9M |
| 2 |
M&T Bank
Buffalo,
New York
|
-$18.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$17.2M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.73M |
